RE: .....................26 Mar 2021 10:12
unvrkw - good questions, but other than the amount of shares that will be issue which is stated, it is very difficult to work out how the market will value the company.
The downside is the placing at 5.00p which I believe will probably be churned very quickly if there are buyers. Apollon current investors and directors are getting shares at 6.00p, but they have a lock-in period, so should not be a problem.
For me, it depends on the revenue generation announcements they make once the RTO completes. They are sounding very bullish and with some patent protected products and formulas, could very much surprise to the upside.
I am going to wait until the RTO completes, and if the share price drops to the 7.00p to 8.00p range, I will buy to reduce my average.
The company certainly sounds like it has the potential and if you forget about the current 'three musketeers' who were allegedly running AfriAg, there is probably a good case for investing in Apollon Formularies. All IMHO.